News Detail
Sweden, 7 Feb 2023: The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate to severe psoriasis; but in this p......
View Details
Source : News Medical Net
Arthritis
Basal Cell Carcinoma
Cancer
Carcinoma
Cell
Dermatology
Drugs
Epidemiology
Health Care
Hospital
Kidney
Kidney Disease
Light Therapy
Liver
Malignant
Medicine
Melanoma
Methotrexate
Psoriasis
Research
Rheumatoid Arthritis
Rheumatology
Skin
Skin Cancer
Squamous Cell Carcinoma
Related News
- Cystic fibrosis drug could help treat pneumonia: Study (14-03-2023)
- Research team of IIT-Roorkee discovers new antibacterial molecule (12-03-2023)
- New pill ‘Bempedoic Acid’ cuts cholesterol, heart attacks (06-03-2023)
- Study: 10% of FDA approved drugs since 2018 had pivotal trials that missed primary endpoints (14-02-2023)
- Drug resistant bacteria secrete toxins: Study (14-02-2023)
- Extracts from 2 wild plants can block Covid-19 virus: Study (11-02-2023)
- Japanese Researchers Developing Device To Detect Brain Tumour Through Urine (04-02-2023)
- Plant toxin Albicidin hailed as 'new weapon' in antibiotic war against bacteria (30-01-2023)
- Gut bacteria affect brain health, mouse study shows (14-01-2023)
- A New Weapon Edoxudine Against Antibiotic-Resistant Bacteria (08-01-2023)